Gateway Genomics Surpasses 200,000 SneakPeek Early Gender DNA Tests Sold with the Acceleration of At-Home Kit Purchases
LA JOLLA, Calif., April 6, 2020 /PRNewswire-PRWeb/ -- Gateway Genomics, leading developer of direct-to-consumer genetic tests that give families insight into their future children, reached 200,000 SneakPeek Early Gender DNA Tests sold in March, just months after attaining the 150,000-test landmark in late 2019.
"SneakPeek was launched as an ecommerce product, where a mom could order her kit online, collect a DNA sample from her home, mail it back for analysis at our lab, and receive her emailed boy-or-girl result, all in days," says Gateway Genomics CEO, Chris Jacob. "Direct-to-consumer is where the expertise of our company lies, and over the years we've optimized our product to be convenient and easy to use right at home. In the current environment of physical distancing, we're grateful to be able to provide families with an alternative solution to learn the gender of their babies that's perfectly suited to staying home and staying safe."
The SneakPeek Test by Gateway Genomics analyzes cell-free fetal DNA found in mom's blood to return just one answer – the gender of her unborn baby. This enables the test to use a very small amount of blood that can be collected at home. Results are emailed as fast as 72 hours after an order is placed online, with 99.1% accuracy for women who are at least 8 weeks into pregnancy, based on peer-reviewed studies.
"We understand this is a difficult situation and time, and not all families will want to or be able to visit their doctors to learn the fetal sex of their baby," continues Mr. Jacob. "Our goal is to ensure that DNA-based prenatal information is accessible and affordable. In these uncertain times, we're proud to deliver a product that gives parents the information they need to make plans, under their control. The SneakPeek Early Gender DNA Test provides a laboratory-proven at-home option to learn a baby's gender and share the joy with family and friends."
This year, Gateway Genomics was ranked #236 in the 38th annual Inc. 500|5000 list of fastest-growing private companies, #23 in the Health sector, in recognition of achieving 1,786% revenue growth in the last three years. The company's principal product, SneakPeek, is an easy-to-use DNA test that lets parents know the gender of their babies as early as 8 weeks into pregnancy, with 99.1% accuracy.
About Gateway Genomics
Gateway Genomics is a personal genomics company with the mission to develop leading-edge genetic tests that give families a new level of understanding about their future children. Since inception, more than 200,000 SneakPeek Early Gender DNA tests have been provided to help new parents bond with their babies, make plans, and connect with friends and family around them. Gateway Genomics is located in La Jolla, CA.
SOURCE Gateway Genomics